Emerging cancer therapy : microbial approaches and biotechnological tools / edited by Arsénio M. Fialho and Ananda M. Chakrabarty.

Explores current and emerging applications of microbes as cancer-fighting agents. Today, treatment options for cancer patients typically include surgery, radiation therapy, immunotherapy, and chemotherapy. While these therapies have saved lives and reduced pain and suffering, cancer still takes mill...

Full description

Saved in:
Bibliographic Details
Other Authors: Fialho, Arsenio, Chakrabarty, Ananda M., 1938-
Format: eBook
Language:English
Published: Hoboken, N.J. : Wiley, ©2010.
Series:Wiley series in biotechnology and bioengineering.
Subjects:
Online Access:Click for online access

MARC

LEADER 00000cam a2200000 a 4500
001 ocn662452551
003 OCoLC
005 20240623213015.0
006 m o d
007 cr cnu---unuuu
008 100907s2010 njua ob 001 0 eng d
010 |z  2009051007 
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d CDX  |d E7B  |d MHW  |d OCLCQ  |d DG1  |d HNW  |d EBLCP  |d OCLCQ  |d YDXCP  |d OCLCQ  |d IDEBK  |d NLGGC  |d OCLCQ  |d COO  |d OCLCQ  |d DEBBG  |d AZK  |d DG1  |d CHVBK  |d MOR  |d LIP  |d PIFAG  |d ZCU  |d OCLCQ  |d MERUC  |d ESU  |d OCLCQ  |d U3W  |d OCLCQ  |d OCLCF  |d OCLCO  |d STF  |d WRM  |d OCLCO  |d COCUF  |d NRAMU  |d ICG  |d INT  |d VT2  |d AU@  |d OCLCO  |d OCLCQ  |d WYU  |d UWO  |d OCLCO  |d OCLCA  |d TKN  |d OCLCO  |d OCLCQ  |d OCLCO  |d DKC  |d OCLCQ  |d OCLCA  |d OCLCO  |d OCLCQ  |d OCLCO  |d VLY  |d UKAHL  |d VHC  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL  |d SXB 
015 |a GBB049456  |2 bnb 
016 7 |a 101521559  |2 DNLM 
016 7 |a 015529398  |2 Uk 
019 |a 657205679  |a 733732297  |a 777631145  |a 816570141  |a 961531424  |a 962630657  |a 1055375870  |a 1064146728  |a 1081287669  |a 1162023095  |a 1228563012  |a 1244448088  |a 1249242723  |a 1303400769 
020 |a 9780470626511  |q (electronic bk.) 
020 |a 0470626518  |q (electronic bk.) 
020 |a 9780470444672  |q (cloth) 
020 |a 0470444673  |q (cloth) 
020 |a 9780470626528  |q (electronic bk.) 
020 |a 0470626526  |q (electronic bk.) 
020 |a 1118035186 
020 |a 9781118035184 
020 |a 1282707698 
020 |a 9781282707696 
020 |a 9786612707698 
020 |a 6612707690 
024 8 |a 9786612707698 
035 |a (OCoLC)662452551  |z (OCoLC)657205679  |z (OCoLC)733732297  |z (OCoLC)777631145  |z (OCoLC)816570141  |z (OCoLC)961531424  |z (OCoLC)962630657  |z (OCoLC)1055375870  |z (OCoLC)1064146728  |z (OCoLC)1081287669  |z (OCoLC)1162023095  |z (OCoLC)1228563012  |z (OCoLC)1244448088  |z (OCoLC)1249242723  |z (OCoLC)1303400769 
037 |a 270769  |b MIL 
050 4 |a RC271.V567  |b E64 2010eb 
072 7 |a MED  |x 062000  |2 bisacsh 
072 7 |a HEA  |x 039030  |2 bisacsh 
049 |a HCDD 
245 0 0 |a Emerging cancer therapy :  |b microbial approaches and biotechnological tools /  |c edited by Arsénio M. Fialho and Ananda M. Chakrabarty. 
260 |a Hoboken, N.J. :  |b Wiley,  |c ©2010. 
300 |a 1 online resource (xiii, 432 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Wiley series in biotechnology and bioengineering 
504 |a Includes bibliographical references and index. 
505 0 |a Salmonella typhimurium mutants selected to grow only in tumors to eradicate them in nude mouse models / Robert M. Hoffman -- The use of living Listeria monocytogenes as an active immunotherapy for the treatment of cancer / John Rothman [and others] -- Bacillus Calmete-Guerin (BCG) for urothelial carcinoma of the bladder / Timothy P. Kresowik and Thomas S. Griffith -- Live clostridia : a powerful tool in tumor biotherapy / Lieve Van Mellaert, Ming Q. Wei, and Jozef Ann -- Bifidobacterium as a delivery system of functional genes for cancer gene therapy / Geng-Feng Fu [and others] -- Replication-selective viruses for the treatment of cancer / Padma Sampath and Steve H. Thorne -- Engineering Herpes simplex virus for cancer oncolytic virotherapy / Jason S. Buhrman, Tooba A. Cheema, and Giulia Fulci -- Promiscuous anticancer drugs from pathogenic bacteria : rational versus intelligent drug design / Arsenio M. Fialho and Ananda M. Chakrabarty -- Arginine Deiminase and cancer therapy / L. Feun [and others] -- Cytosine deaminase/5-fluorocytosine molecular cancer chemotherapy / Sergey A. Kaliberov and Donald J. Buchsbaum -- Bacterial proteins against metastasis / A.M.E. Walenkamp -- Pseudomonas exotoxin A-based immunotoxins for targeted cancer therapy / Philipp Wolf and Ursula Elsesser-Beile -- Denileukin Diftitox in novel cancer therapy / Lin-Chi Chen and Nam H. Dang -- The application of cationic antimicrobial peptides in cancer treatment : laboratory investigations and clinical potential / Ashley Hilchie and David W. Hoskin -- Prodiginines and their potential utility as proapoptotic anticancer agents / Neil R. Williamson [and others] -- Farnesyltransferase inhibitors of microbial origins in cancer therapy / Jingxuan Pan and Sai-Ching Jim Yeung -- The use of RNA and CpG dna as nucleic acid-based therapeutics / Jorg Vollmer -- The role and importance of intellectual property generation and protection in drug development / Arsenio M. Fialho and Ananda M. Chakrabarty. 
520 |a Explores current and emerging applications of microbes as cancer-fighting agents. Today, treatment options for cancer patients typically include surgery, radiation therapy, immunotherapy, and chemotherapy. While these therapies have saved lives and reduced pain and suffering, cancer still takes millions of lives every year around the world. In recent years, researchers have been working on a new strategy: developing microbes and microbial products that specifically attack cancer cells. This book breaks new ground in emerging cancer treatment modalities by presenting recent advances in the use of microorganisms and viruses as well as their products in cancer therapy. Seventeen chapters review the application of live microorganisms, high and low molecular weight products derived from microorganisms, and microbial products fused to cancer-targeting molecules. In addition, the book highlights the benefits of a multi-target approach to destroy cancer cells. --From publisher's description. 
588 0 |a Print version record. 
546 |a English. 
650 0 |a Cancer  |x Treatment. 
650 0 |a Viruses  |x Therapeutic use. 
650 0 |a Bacteria  |x Therapeutic use. 
650 0 |a Microbial biotechnology. 
650 7 |a bioengineering.  |2 aat 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a Cancer  |x Treatment  |2 fast 
650 7 |a Microbial biotechnology  |2 fast 
650 7 |a Viruses  |x Therapeutic use  |2 fast 
700 1 |a Fialho, Arsenio. 
700 1 |a Chakrabarty, Ananda M.,  |d 1938-  |1 https://id.oclc.org/worldcat/entity/E39PCjJJ6JfBCRTctbfgVx3Hfq 
758 |i has work:  |a Emerging cancer therapy (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGhBRWPBTK8PGBkhKGrJcP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Emerging cancer therapy.  |d Hoboken, N.J. : Wiley, ©2010  |z 9780470444672  |w (DLC) 2009051007  |w (OCoLC)494663364 
830 0 |a Wiley series in biotechnology and bioengineering. 
856 4 0 |u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=564932  |y Click for online access 
903 |a EBC-AC 
994 |a 92  |b HCD